Sep 18, 2026 · 12 min
Press access, Russian gas and drugmaking move into new orbit
Trump press ban, Saudi stealth jets, drugs in space (Updated)
The episode connects threats to press freedom, shipping security, political dissent, energy dependence and the next frontier of pharmaceutical research.
- 1Trump’s White House press ban renews questions about First Amendment protections and the administration’s relationship with news organizations.
- 2Houthi pressure near the Bab al-Mandeb Strait and possible Russian gas talks expose competing risks to security and energy independence.
- 3Commercial space stations could give pharmaceutical companies new environments for developing drugs and human tissues as the ISS nears retirement.
Don't miss
Nancy Lapid describes how commercial space stations could support pharmaceutical research and human-tissue development beyond the International Space Station.
The brief
Donald Trump’s decision to bar CNN, MSNOW and Politico from the White House raises fresh concerns about press access and First Amendment protections.
Fighting in Yemen is moving closer to the Bab al-Mandeb Strait, where Houthi control of the western coast could threaten a crucial shipping route and pressure Saudi Arabia.
Japan’s central bank raises its policy rate to 1.25%, while Russia’s limited opposition space and Germany’s possible return to Russian gas reveal different forms of political and economic risk.
A federal judge orders 30 days’ notice before steps toward demolishing the Kennedy Center, while Warren Buffett prepares to leave Berkshire Hathaway’s chairmanship.
Nancy Lapid explains why pharmaceutical startups are expanding research in orbit: commercial space stations may offer new ways to develop drugs and human tissues after the ISS era.